{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1101/776500",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/MPS-Db",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3336"
        },
        {
          "@id": "edam:topic_3379"
        },
        {
          "@id": "edam:topic_3375"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/776500"
      },
      "sc:description": "Applications of the Microphysiology Systems Database for Experimental ADME-Tox and Disease Models | The MPS-Db aggregates MPS data with linked preclinical and clinical databases for analysis in the context of human exposure. Built in agents enable the assessment of the reproducibility and transferability of MPS models, while computational models are being developed to enhance the value of MPS models for understanding disease mechanisms, compound toxicity, and prediction of drug pharmacokinetics (PK)",
      "sc:featureList": {
        "@id": "edam:operation_3436"
      },
      "sc:name": "MPS-Db",
      "sc:url": "https://mps.csb.pitt.edu"
    }
  ]
}